Alkermes
ALKS
#2348
Rank
C$11.10 B
Marketcap
C$66.07
Share price
-1.43%
Change (1 day)
61.45%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): C$0.24 Billion

According to Alkermes's latest financial reports the company's current earnings are C$1.65 Billion. In 2025 the company made an earning of C$0.43 Billion a decrease over its 2024 earnings that were of C$0.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.24 B-44.1%
2025 C$0.43 B-34.87%
2024 C$0.66 B-17.97%
2023 C$0.81 B-468.52%
2022 -C$0.23 Billion449.24%
2021 -C$40.19 Million-68.04%
2020 -C$0.13 Billion-52.1%
2019 -C$0.27 Billion64.49%
2018 -C$0.16 Billion-15.04%
2017 -C$0.19 Billion-34.2%
2016 -C$0.29 Billion-5.34%
2015 -C$0.31 Billion35084.97%
2014 -C$0.86 Million
2012 C$10.61 M-117.81%
2011 -C$59.64 Million-12.69%
2010 -C$68.3 Million94.3%
2009 -C$35.16 Million-117.7%
2008 C$0.19 B622.63%
2007 C$27.48 M
2004 -C$0.11 Billion-14.48%
2003 -C$0.13 Billion11.88%
2002 -C$0.12 Billion39.65%
2001 -C$81.35 Million5.73%
2000 -C$76.94 Million-28.91%
1999 -C$0.11 Billion237.28%
1998 -C$32.09 Million100.05%
1997 -C$16.04 Million-37.93%
1996 -C$25.84 Million82.72%
1995 -C$14.15 Million-26.79%
1994 -C$19.32 Million-72.78%
1993 -C$70.97 Million208.07%
1992 -C$23.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.78 B 10,618.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$18.08 B 7,138.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.96 B 3,889.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$11.14 B 4,359.14%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$16.21 B 6,388.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$21.58 B 8,539.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-C$0.31 Billion-221.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-C$0.39 Billion-255.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.75 B 600.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel